Possati-Resende Júlio César, Vazquez Fabiana de Lima, Biot Sinval Tadeu, Mauad Edmundo Carvalho, Talarico Thais, Fregnani José Humberto Tavares Guerreiro, Longatto-Filho Adhemar
Cancer Prevention Department, Barretos Cancer Hospital, Barretos, Brazil.
Acta Cytol. 2018;62(1):19-27. doi: 10.1159/000480446. Epub 2017 Oct 26.
The aim of this report is to demonstrate the Barretos Cancer Hospital initiative of organizational, laboratorial, and human resources training in the implementation of an organized cervical screening program in low-resource settings.
We developed a computational program to report all epidemiological, clinical, and laboratorial findings, and to trace all necessary information to recruit women for regular screening or for referral for complementary exams after liquid-based Pap test analyses.
All Pap tests were collected in liquid medium and in 2014 more than 160,000 tests were analyzed and 2,900 colposcopy examinations were performed. From 2012 to 2015, the percentage of exams collected increased from 54.6% in 2012 to 62.4% in 2013, 68.4% in 2014, and 71% in 2015. Per 1,000 Pap tests, 0.4 cases of invasive cancer were diagnosed; for in situ carcinoma, 1.9 cases were identified. More importantly, between 2011 and 2015, 89.4% of all carcinomas were detected at clinical stage 0 or I (in situ carcinoma), and only 5% at stages III and IV.
Since the organized system was implemented, 98% of women have attended their recall for colposcopy. So far, we have not reached the target of 70% of women for this proposal, as recommended by the international standards.
本报告旨在展示巴雷托斯癌症医院在资源匮乏地区实施有组织的宫颈癌筛查项目时,在组织、实验室和人力资源培训方面所采取的举措。
我们开发了一个计算程序,用于报告所有流行病学、临床和实验室检查结果,并追踪所有必要信息,以便招募女性进行定期筛查,或在液基巴氏试验分析后将其转诊进行补充检查。
所有巴氏试验均在液体介质中采集,2014年分析了超过160,000份试验,并进行了2,900次阴道镜检查。从2012年到2015年,采集的检查比例从2012年的54.6%增至2013年的62.4%、2014年的68.4%和2015年的71%。每1000份巴氏试验中,诊断出0.4例浸润癌;原位癌确诊1.9例。更重要的是,在2011年至2015年期间,所有癌症中有89.4%在临床0期或I期(原位癌)被检测到,而在III期和IV期仅为5%。
自实施该有组织的系统以来,98%的女性已参加阴道镜复查召回。到目前为止,我们尚未达到国际标准所建议的该提议中70%女性的目标。